Case Reports in Obstetrics and Gynecology

Volume 2013 (2013), Article ID 356560, 5 pages

http://dx.doi.org/10.1155/2013/356560

Case Report

Liver Transplantation during Pregnancy for Acute Liver Failure due to HBV Infection: A Case Report

Nina Kimmich,¹ Philipp Dutkowski,² Franziska Krähenmann,¹ Beat Müllhaupt,³ Roland Zimmermann,¹ and Nicole Ochsenbein-Kölble¹

¹Department of Obstetrics, University Hospital of Zurich, Frauenklinikstrasse 10, 8091 Zurich, Switzerland

²Department of Surgery and Transplantation, University Hospital of Zurich, Frauenklinikstrasse 10, 8091 Zurich, Switzerland

³Department of Gastroenterology and Hepatology, University Hospital of Zurich and Swiss HPB Center, Switzerland

Received 8 September 2013; Accepted 28 October 2013

Academic Editors: P. Kovacs and P. Schuetze

Copyright © 2013 Nina Kimmich et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Acute hepatic failure during pregnancy is a life-threatening situation for the mother and fetus and might need a super-urgent liver transplantation. Many pregnancies with positive outcomes are reported after a previous liver transplantation before the pregnancy, but only a few of them are mentioned with transplantation during pregnancy. In these few cases, fetal outcome is mostly adverse. Experience with liver failure during pregnancy and its management is still deficient and needs to be approved. For sure, patients need to be treated in highly qualified centers in a multidisciplinary approach. We present a case of successful super-urgent liver transplantation during the second trimester of pregnancy after acute hepatic failure due to an acute hepatitis B infection with positive maternal and fetal outcome. Liver transplantation during pregnancy due to an acute liver failure can be a life-saving procedure for the mother and fetus. An early initiated maternal therapy with antiviral drugs and immunoglobulins seems to be safe and able to prevent fetal infection and immunosuppressive therapy after transplantation seems to be well tolerated. Nevertheless, fetal outcome differs widely and long-term outcome is deficiently known.

1. Introduction

Acute hepatic failure is always a life-threatening situation. Sometimes, the only solution solving the problem is a super-urgent liver transplantation. An ongoing pregnancy aggravates such a situation, as two people’s lives are involved, the one of the mother and the fetus. Many pregnancies with positive outcomes are reported after liver transplantation before getting pregnant, but only a few cases are mentioned with transplantation during pregnancy [1–21].

2. Case Presentation

A 30-year-old primigravida at 22 0/7 gestational weeks (GW) was admitted to our hospital in suspicion of an acute hepatitis B infection. She had presented herself in another hospital with slight nausea and vomiting, pruritus, slight jaundice, dark urine, a fairly affected overall condition, and a positive blood test for acute hepatitis B infection. The source of the infection remained unknown. Her blood pressure, heart rate, and oxygen saturation were normal, as well as her urine analysis besides an elevated bilirubin level. She showed no signs of edema or hyperreflexia but slight jaundice and icteric sclera. Her cardiac and pulmonary status was unaffected, and her temperature was elevated to 38.8°C. Her laboratory work-up showed a progressive hepatic failure (Table 1). HELLP syndrome, intoxication with acetaminophen, Wilson’s disease, hepatic neoplasia, acute fatty liver of pregnancy, autoimmune hepatitis, and alpha-1-antitrypsin deficiency as other potential etiologies of acute liver failure were excluded by laboratory testing. The infection screening revealed an acute hepatitis B infection with a viral load of 170.000.000 IU/mL. Other infections as hepatitis A, hepatitis C, HIV, cytomegalovirus (CMV), epstein barr virus, herpes simplex virus, varicella zoster virus, syphilis, toxoplasmosis, and parvovirus B19 could be excluded. Her personal medical history showed only an infection with chlamydia trachomatis in early pregnancy, which had been treated with azithromycin. Her family history revealed no cases of known hepatitis B infections. The fetus was sonographically unaffected and well developed according to her gestational age at admission. A multidisciplinary team of hepatologists, surgeons, and obstetricians took care of the patient. An antiviral therapy with tenofovir, 245 mg orally once a day, was initiated immediately. But the patient, who dearly wanted to keep the pregnancy, had to be added to the super-urgent liver transplantation list two days after admission according to Clichy criteria because of rapid progression of hepatic failure and encephalopathy (lab MELD 33) (Table 1). After graft allocation and within 24 hours, an orthotopic liver transplantation with cava preserving technique (piggy back) and intermittent portocaval shunt was performed to avoid any cava clamping during transplantation. The operation was uneventful (six-hour surgery, transfusion of 2 U red blood cells, and low pressors). Intraoperatively, an additional treatment with hepatitis B immunoglobulin was started and continued for 10 days in a dose of 10.000 IU per day intravenously. Thereafter, it was continued to maintain the anti-HBs titer >100 IU/mL. Postoperatively, treatment with tenofovir was continued until 28 6/7 GW. Afterwards, it was changed to lamivudine 100 mg p.o. daily because of an increase of liver enzymes. Immunosuppression consisted of corticosteroids and tacrolimus. The corticosteroids were applied intravenously for the first five days postoperatively in declining doses of methylprednisolone from 250 to 40 mg, followed by decreasing doses of prednisolone orally from 20 mg to 5 mg until delivery. Tacrolimus was applied orally in doses between 5 mg and 12 mg with the goal to achieve a blood level of six to eight ng/mL. On the first postoperative day, the patient could be extubated without any problems and recovered quickly. The histopathological examination of the explanted liver confirmed subtotal necrosis of the liver with extensive cholestasis and predominantly lymphocytic hepatitis. Subsequent maternal sonographic controls and laboratory testing showed normal liver function and perfusion. Subsequent biopsies of the transplanted liver due to elevated liver enzymes at day six after transplantation, could exclude a graft rejection. Eleven days after liver transplantation fetal sonography revealed hepatomegaly and intracranial ventriculomegaly (Figure 1(a)). Additionally, small hematomas in the plexus choroideus on both sides and a subdural bleeding in the posterior cranial fossa were detected (Figure 1(b)). Therefore, an additional MRI of the fetus was arranged five days later and confirmed a mild ventriculomegaly on both sides. However, the hepatomegaly could not be confirmed. Repeated sonographic and MRI examinations showed total restitution of the former findings during the course of pregnancy (Figure 1(c)). Because the patient suffered from preterm uterine contractions, tocolytic agents in form of nifedipine 60 mg orally twice a day in an off-label-use were applied and had to be changed to intravenous admission of hexoprenaline at 28 4/7 GW because of ongoing contractions. The patient developed gestational diabetes, which could be well controlled by diet. With 34 GW a CMV reactivation was detected and treated with CMV immunoglobulins intravenously. An elective cesarean delivery was performed at 36 0/7 GW due to increasing discomfort and strong demand of the patient. A healthy male newborn of 2700 g (42. percentile) was delivered with an APGAR score of 6-4-7 and an umbilical artery pH of 7.39. The child was transferred to our neonatal intensive care unit for better surveillance. A fetal hepatitis B and CMV infection could be excluded by serological testing of the fetal blood and urine. The mother’s and child’s course were uneventful and they were dismissed eight and 20 days after the cesarean section, respectively.

Table 1: Maternal laboratory values.

Day of admission, 22 0/7 GW
Day of transplantation, 22 3/7 GW
Two days after transplantation, 22 5/7 GW
Discharge of hospital (110 days after transplantation)

Hb in g/L (117–153)
111
83
64
133

Tc in G/L (143–400)
173
194
137
249

INR (<1.2)
1.6
4.6
1.2
1.1

Factor 5 in % (50–150)
27
15
79

Bilirubin in mcM/L (<21)
129
184
37
7

Ammoniac in mcM/L (9–30)
17
49
14

AST in U/L (<35)
4030
1749
347
20

ALT in U/L (10–35)
2775
2272
824
12

GGT in U/L (5–36)
19
17

HBV-DNA IU/mL (0)

<20

HBs-Ag in U/mL (<0.05)
pos

2748.68
0

Anti-HBs U/L (<10)
neg

17
787

HBe-Ag (neg)
pos

neg

Anti-HBe (neg)
pos

pos

Anti-HBc-IgM (neg)
pos

pos

(a) Ventriculomegaly on both sides

(b) Subdural bleeding in the posterior cranial fossa

(c) Normal seized ventricles

Figure 1: Sonographic images.

3. Discussion

Acute liver failure during pregnancy is a rare but potentially life-threatening disease. Causes of acute liver failure can be pre-existing, pregnancy related, or can occur during pregnancy without being directly related to it (Table 2). Depending on the age of gestation and the viability of the fetus, termination of pregnancy before or during transplantation or maintaining pregnancy has to be discussed with the patient. A multidisciplinary approach is mandatory and the treatment of patients with acute liver failure during pregnancy should take place in a highly qualified and specialized center.

Table 2: Causes of acute hepatic failure during pregnancy.

Causes of hepatic failure
Pregnancy related
Nonpregnancy related
Testing

HELLP syndrome
x

Thrombocytes, liver enzymes, hemolysis parameters (LDH, haptoglobin)

Acute fatty liver of pregnancy
x

Long-chain fatty acids (LCHAD), acylcarnitine

Infections

x
Serological blood testing

Intoxications (drugs, medication)

x
Urine/blood testing (qualitative/quantitative drug proof)

Metabolic disorders (e.g., M. Wilson)

x
Special markers (e.g., ceruloplasmin, alpha-1-antitrypsin), biopsy

Tumors

x
Imaging, biopsy, tumor markers (e.g., AFP)

Autoimmune disorders

x
Autoantibodies, biopsy

Besides our case, 18 other cases of liver transplantation during pregnancy were described (Table 3). The reasons for transplantation were acute liver failure due to different etiologies (Table 3). All liver transplantation procedures were performed with piggy back technique. According to current guidelines, immunosuppressive treatment mostly consists of a combination of a calcineurin inhibitor (e.g., tacrolimus) and corticosteroids [19, 21, 22], as it was in our patient. She tolerated the medication without any problems.

Table 3: Eighteen other cases of liver transplantation during pregnancy in the literature.

Publication
GW at transplantation
Etiology
Maternal outcome
Delivery mode, GW
Fetal outcome

Anders et al. [1]
20
Unknown
Survived
Curettage, 20 GW
Intrauterine fetal death (IUFD)

Catnach et al. [2]
20
Autoimmune
Survived, PPROM
Spontaneous, 28 GW
Survived

Eguchi et al. [3]
15
Unknown
Survived, cytomegaly infection
Curettage, 20 GW
Abortion

Fair et al. [4]
22
Hepatitis B
Survived, Retransplantation
Cesarean, 30 GW
Survived, intrauterine growth restriction (IUGR)

Finlay et al. [5]
17.5
Unknown
Survived
Spontaneous, 28.5 GW
IUFD

Hamilton et al. [6]
21
Hepatitis B
Survived
Spontaneous, 22 GW
IUFD

Jarufe et al. [7]
22
Unknown
Survived, reoperation (biliary stenosis), mild graft reaction, preterm contractions
Spontaneous, 27 GW
Survived, no compromises

Laifer et al. [8]
26
Hepatitis B
Survived, Retransplantation
Cesarean, 28 GW
Neonatal death

Laifer et al. [9]
23
Autoimmune
Survived; infection, renal insufficiency, anemia, thrombozytopenia, hypotension graft reaction
Spontaneous, 23 GW
IUFD

Lo et al. [10]
26
Unknown
Survived
Spontaneous, 26 GW
IUFD 26

Kato et al. [11]
13
Unknown
Survived, reoperation (insufficient biliary anastomosis)
Miscarriage, 13 GW
Miscarriage

Moreno et al. [12]
27
Unknown
Survived
Cesarean, term
Survived

Morris et al. [13]
27
Drug (PTU)
Survived
Spontaneous, 27 GW
Neonatal death

Sequeira et al. [14]
18
Drug (PTU)
Survived
Cesarean, 37 GW
IUGR, microcephaly, oligohydramnion, ventriculomegaly, ischemic enzephalopathy, seizures

Jankovic et al. [15]
13.5
Autoimmune
Survived
Spontaneous, 36 GW
No compromises

Maddukuri et al. [16]
11
Unknown
Survived
Spontaneous, 30 GW
Normally developed at age of 4 years

Simsek et al. [17]
18
Hepatitis A
Survived
Induced abortion 18 GW
Abortion, growth restriction, oligohydramnion

Thornton and Minns [18]
20 5/7
Drug
Survived
Induced abortion
Abortion, hydrops, bilateral ventriculomegaly

Described side effects during pregnancy after liver transplantation, when transplantation was performed before the begin of a pregnancy, are hypertension (26–46%), preeclampsia (9–26%), cholestasis (3–27%), graft rejection (7–12%), diabetes (5–13%), osteoporosis, neurotoxicity, impaired maternal renal function, maternal infections (9–27%), cesarean delivery (23–47%), preterm delivery (31–39%), fetal growth restriction (17–34%), indistinct fetal malformations (0–3%), and complications of the newborn (17–33%) with a perinatal mortality of 0–4% [19–24].

Side effects after transplantation during the ongoing pregnancy in the 18 cases differed little, with cholestasis (22%), graft rejections (25%), impaired maternal renal function (6%), maternal infections (13%), cesarean delivery (25%), preterm delivery (44%), fetal growth restriction (22%), complications of the newborn (19%), and perinatal mortality (50%) [1–18]. Concerning our case, maternal complications in form of a steroid induced gestational diabetes, a reactivation of CMV-infection due to the immunosuppressive medication and preterm contractions, well controlled by tocolysis, took place. No serious complications were found. Concerning the fetus, intermittent intracranial ventriculomegaly and intracranial bleeding with a total restitution in the further course of pregnancy were documented. The reason for these intermittent changes was unclear. By treating the mother with antiviral drugs and immunoglobulins against hepatitis B and CMV, an infection of the newborn could be successfully prevented. In the end, a normally sized and developed newborn was delivered almost at term. Its development a year after the birth its absolutely normal and uncomplicated, but the neurological long-term outcome is still unknown. In comparison, fetal outcome in the other 18 cases described in the literature showed a wide range from abortion to delivery of a normal fetus (Table 3).

We conclude that super-urgent liver transplantation due to an acute hepatitis B infection during pregnancy can be a life-saving procedure for the mother and fetus. An early initiated maternal therapy with antiviral drugs and immunoglobulins seems to be safe and able to prevent fetal infection. Although perinatal mortality is high, on one hand, because of intrauterine fetal death in the course and on the other hand, because of induced abortion for fear of fetal complications, maintaining the pregnancy should always be discussed with the mother. As especially our case and few others show, maintaining the pregnancy is an option in case of acute liver failure with the necessity of transplantation and positive outcome is possible. Nevertheless, fetal outcomes after transplantation during pregnancy are diverse and long-term outcomes are deficiently known. But as our case shows, there are good chances of positive outcome for affected patients and their offspring as long as they are treated in highly specialized centers with intense treatment and observation.

References

M. Anders, E. Quiñonez, N. Goldaracena, J. Osatnik, J. L. Fernández, and L. Viola, “Liver transplantation during pregnancy in a patient with acute liver failure,” Acta Gastroenterologica Latinoamericana, vol. 40, pp. 268–270, 2010.

S. M. Catnach, M. McCarthy, E. Jauniaux et al., “Liver transplantation during pregnancy complicated by cytomegalovirus infection,” Transplantation, vol. 60, no. 5, pp. 510–511, 1995.

S. Eguchi, K. Yanaga, F. Fujita et al., “Living-related right lobe liver transplantation for a patient with fulminant hepatic failure during the second trimester of pregnancy: report of a case,” Transplantation, vol. 73, no. 12, pp. 1970–1971, 2002.

J. Fair, A. S. Klein, T. Feng, W. T. Merritt, and J. F. Burdick, “Intrapartum orthotopic liver transplantation with successful outcome of pregnancy,” Transplantation, vol. 50, no. 3, pp. 534–535, 1990.

D. E. Finlay, M. C. Foshager, D. G. Longley, and J. G. Letourneau, “Ischemic injury to the fetus after maternal liver transplantation,” Journal of Ultrasound in Medicine, vol. 13, no. 2, pp. 145–148, 1994.

M. I. R. Hamilton, R. Alcock, L. Magos, S. Mallett, K. Rolles, and A. K. Burroughs, “Liver transplantation during pregnancy,” Transplantation Proceedings, vol. 25, no. 5, pp. 2967–2968, 1993.

N. Jarufe, A. Soza, R. M. Pérez-Ayuso et al., “Successful liver transplantation and delivery in a woman with fulminant hepatic failure occurring during the second trimester of pregnancy,” Liver International, vol. 26, no. 4, pp. 494–497, 2006.

S. A. Laifer, M. J. Darby, V. P. Scantlebury, J. H. Harger, and S. N. Caritis, “Pregnancy and liver transplantation,” Obstetrics and Gynecology, vol. 76, no. 6, pp. 1083–1088, 1990.

S. A. Laifer, K. Abu-Elmagd, and J. J. Fung, “Hepatic transplantation during pregnancy and the puerperium,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 6, no. 1, pp. 40–44, 1997.

C. M. Lo, P. Gertsch, and S. T. Fan, “Living unrelated liver transplantation between spouses for fulminant hepatic failure,” British Journal of Surgery, vol. 82, no. 8, pp. 1036–1037, 1995.

T. Kato, J. R. Nery, J. J. Morcos et al., “Successful living related liver transplantation in an adult with fulminant hepatic failure,” Transplantation, vol. 64, no. 3, pp. 415–417, 1997.

E. G. Moreno, G. I. Garcia, S. R. Gomez et al., “Fulminant hepatic failure during pregnancy successfully treated by orthotopic liver transplantation,” Transplantation, vol. 52, no. 5, pp. 923–926, 1991.

C. V. Morris, R. M. Goldstein, J. B. Cofer, H. Solomon, and G. B. Klintmalm, “An unusual presentation of fulminant hepatic failure secondary to propylthiouracil therapy,” Clinical Transplants, 1989, article 311.

E. Sequeira, S. Wanyonyi, and R. Dodia, “Severe propylthiouracil-induced hepatotoxicity in pregnancy managed successfully by liver transplantation: a case report,” Journal of Medical Case Reports, vol. 5, article 461, 2011.

Z. Jankovic, D. Stamenkovic, B. Duncan, R. Prasad, and M. Davies, “Successful outcome after a technically challenging liver transplant during pregnancy,” Transplantation Proceedings, vol. 39, no. 5, pp. 1704–1706, 2007.

V. C. Maddukuri, C. D. Stephenson, L. Eskind, W. A. Ahrens, P. Purdum, and M. W. Russo, “Liver transplantation for acute liver failure at 11-week gestation with successful maternal and fetal outcome,” Case Reports in Transplantation, vol. 2012, Article ID 484080, 7 pages, 2012.

Y. Simsek, B. Isik, A. Karaer, O. Celik, R. Kutlu, and N. E. Aydin, “Fulminant hepatitis A infection in second trimester of pregnancy requiring living-donor liver transplantation,” Journal of Obstetrics and Gynaecology Research, vol. 38, no. 4, pp. 745–748, 2012.

S. L. Thornton and A. B. Minns, “Unintenional chronic acetaminophen poisoning during pregnancy resulting in liver transplantation,” Journal of Medical Toxicology, vol. 8, no. 2, pp. 176–178, 2012.

M. B. Parolin, J. C. U. Coelho, A. A. Urbanetz, and M. Pampuch, “Contraception and pregnancy after liver transplantation—an update overview,” Arquivos de Gastroenterologia, vol. 46, no. 2, pp. 154–158, 2009.

M. F. dei Malatesta, M. Rossi, B. Rocca et al., “Pregnancy after liver transplantation: report of 8 new cases and review of the literature,” Transplant Immunology, vol. 15, no. 4, pp. 297–302, 2006.

J. S. Radomski, M. J. Moritz, S. J. Muñoz, J. R. Cater, B. E. Jarrell, and V. T. Armenti, “National Transplantation Pregnancy Registry: analysis of pregnancy outcomes in female liver transplant recipients,” Liver Transplantation and Surgery, vol. 1, no. 5, pp. 281–284, 1995.

S. Mukherjee and U. Mukherjee, “A comprehensive review of immunosuppression used for liver transplantation,” Journal of Transplantation, vol. 2009, Article ID 701464, 20 pages, 2009.

V. T. Armenti, S. Constantinescu, M. J. Moritz, and J. M. Davison, “Pregnancy after transplantation,” Transplantation Reviews, vol. 22, no. 4, pp. 223–240, 2008.

V. T. Armenti, S. K. Herrine, J. S. Radomski, and M. J. Moritz, “Pregnancy after liver transplantation,” Liver Transplantation, vol. 6, no. 6, pp. 671–685, 2000.